Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $3,549 - $5,615
100 New
100 $4,000
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $3.63 Million - $8.39 Million
68,200 New
68,200 $4.04 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $1.19 Million - $1.55 Million
-10,100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $224,542 - $291,099
-1,900 Reduced 15.83%
10,100 $1.52 Million
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $1.12 Million - $1.55 Million
12,000 New
12,000 $1.43 Million
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $2.16 Million - $2.78 Million
-26,600 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $2.37 Million - $3.05 Million
-29,200 Reduced 52.33%
26,600 $2.35 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $20.8 Million - $29.4 Million
-241,200 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$86.4 - $121.75 $4.82 Million - $6.79 Million
55,800 New
55,800 $5.34 Million
Q3 2020

Nov 13, 2020

BUY
$95.43 - $116.09 $19.8 Million - $24.1 Million
207,400 Added 613.61%
241,200 $27.4 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $1.29 Million - $2.12 Million
21,400 Added 172.58%
33,800 $3.35 Million
Q1 2020

May 15, 2020

SELL
$47.37 - $90.04 $1.94 Million - $3.68 Million
-40,900 Reduced 76.74%
12,400 $793,000
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $6.14 Million - $8.23 Million
-115,600 Reduced 68.44%
53,300 $3.18 Million
Q3 2019

Nov 14, 2019

BUY
$57.11 - $73.3 $5.68 Million - $7.29 Million
99,400 Added 143.02%
168,900 $9.96 Million
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $1.01 Million - $1.33 Million
18,600 Added 36.54%
69,500 $4.48 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $5.97 Million - $13.6 Million
-185,200 Reduced 78.44%
50,900 $3.23 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $5.05 Million - $12.1 Million
236,100 New
236,100 $10.1 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.93B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.